zeno@Mac oncobot-v3 % pnpm dev                                                                             

> oncobot@0.1.0 dev /Users/zeno/Projects/oncobot-v3
> next dev --turbopack

   ‚ñ≤ Next.js 15.4.2 (Turbopack)
   - Local:        http://localhost:3000
   - Network:      http://192.168.1.166:3000
   - Environments: .env
   - Experiments (use with caution):
     ‚úì useCache
     ¬∑ staleTimes
     ¬∑ serverActions
     ¬∑ ...

 ‚úì Starting...
 ‚úì Compiled middleware in 65ms
 ‚úì Ready in 677ms
Pathname:  /
 ‚óã Compiling / ...
 ‚úì Compiled / in 6.3s
[Feature Toggle] Environment variable NEXT_PUBLIC_ENABLED_SEARCH_MODES: health
[Feature Toggle] Parsed modes: [ 'health' ]
[Feature Toggle] Mode web is disabled
[Feature Toggle] Mode memory is disabled
[Feature Toggle] Mode analysis is disabled
[Feature Toggle] Mode crypto is disabled
[Feature Toggle] Mode chat is disabled
[Feature Toggle] Mode x is disabled
[Feature Toggle] Mode reddit is disabled
[Feature Toggle] Mode academic is disabled
[Feature Toggle] Mode youtube is disabled
[Feature Toggle] Mode extreme is disabled
[Feature Toggle] Mode health is enabled
[Feature Toggle] Mode extreme is disabled
 GET / 200 in 7198ms
Pathname:  /
Pathname:  /api/auth/get-session
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "expires_at", "token", "created_at", "updated_at", "ip_address", "user_agent", "user_id
 ‚óã Compiling /api/auth/[...all] ...
DB Query: select "id", "name", "email", "email_verified", "image", "created_at", "updated_at" from "user" wher
 POST / 200 in 676ms
Pathname:  /
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 POST / 200 in 136ms
 GET /manifest.webmanifest 200 in 837ms
Pathname:  /
DB Query: select "userHealthProfile"."id", "userHealthProfile"."user_id", "userHealthProfile"."health_profile_
 GET /favicon.ico 200 in 907ms
 POST / 200 in 135ms
 GET /apple-icon.png 200 in 442ms
 ‚úì Compiled /api/auth/[...all] in 1501ms
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "expires_at", "token", "created_at", "updated_at", "ip_address", "user_agent", "user_id
DB Query: select "id", "name", "email", "email_verified", "image", "created_at", "updated_at" from "user" wher
 GET /api/auth/get-session 200 in 2586ms
Pathname:  /api/search
 ‚óã Compiling /api/search ...
 ‚úì Compiled /api/search in 1309ms
üîç Search API endpoint hit
--------------------------------
Location:  undefined undefined
--------------------------------
--------------------------------
Messages:  [
  {
    id: 'dQFqu6X3ZhzLA8Zq',
    createdAt: '2025-08-06T21:01:20.077Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  }
]
--------------------------------
DB Query: select "id", "expires_at", "token", "created_at", "updated_at", "ip_address", "user_agent", "user_id
DB Query: select "id", "name", "email", "email_verified", "image", "created_at", "updated_at" from "user" wher
‚è±Ô∏è  User check took: 0.37s
DB Query: select "id", "user_id", "content", "created_at", "updated_at" from "custom_instructions" where "cust
 > Resumable streams initialized successfully
‚è±Ô∏è  Critical checks wait took: 0.01s
[Feature Toggle] Environment variable NEXT_PUBLIC_ENABLED_SEARCH_MODES: health
[Feature Toggle] Parsed modes: [ 'health' ]
[Feature Toggle] Mode health is enabled
‚è±Ô∏è  Config loading took: 0.01s
‚è±Ô∏è  Config wait took: 0.00s
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."i
‚è±Ô∏è  Chat check took: 0.06s
DB Query: insert into "chat" ("id", "userId", "title", "created_at", "updated_at", "visibility") values ($1, $
‚è±Ô∏è  Chat creation took: 0.08s
--------------------------------
Messages:  [
  {
    id: 'dQFqu6X3ZhzLA8Zq',
    createdAt: '2025-08-06T21:01:20.077Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  }
]
--------------------------------
Running with model:  oncobot-default
Group:  health
Timezone:  America/Chicago
Context Decision: {
  strategy: 'minimal',
  reasoning: 'Initial query - no history needed',
  includeFromHistory: 0,
  compressionLevel: 'none'
}
DB Query: insert into "message" ("id", "chat_id", "role", "parts", "attachments", "created_at") values ($1, $2
‚è±Ô∏è  Context optimization took: 0.00s
üìä Token usage: 20 ‚Üí 27 (-35.0% reduction)
--------------------------------
Time to reach streamText: 0.62 seconds
--------------------------------
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: insert into "stream" ("id", "chatId", "createdAt") values ($1, $2, $3)
‚è±Ô∏è  Background operations took: 0.65s
--------------------------------
Messages saved:  [
  {
    id: 'dQFqu6X3ZhzLA8Zq',
    createdAt: '2025-08-06T21:01:20.077Z',
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?',
    parts: [ [Object] ]
  }
]
--------------------------------
Pathname:  /search/8126abfc-6155-40f4-8578-6970d0964439
 ‚óã Compiling /search/[id] ...
 ‚úì Compiled /search/[id] in 1754ms
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 POST /search/8126abfc-6155-40f4-8578-6970d0964439 200 in 2274ms
Called Tool:  clinical_trials
DB Query: select "userHealthProfile"."id", "userHealthProfile"."user_id", "userHealthProfile"."health_profile_
DB Query: select "id", "health_profile_id", "question_id", "response", "created_at" from "health_profile_respo
Generated search queries: [
  'NSCLC KRAS G12C',
  'Thoracic NSCLC targeted therapy',
  'NSCLC immunotherapy trials',
  'KRAS G12C lung cancer therapy'
]
Found 61 unique trials from 80 total
Warnings:  []
Warnings:  []
Fin reason:  stop
Reasoning:  First, the user asked: "Are there any trials for my type and stage of cancer?" This is a health-related query, so I must use the clinical_trials tool immediately, which I did in my previous response.

In my initial response, I called the clinical_trials function, and now I'm receiving the results from that function call. The results show trials related to NSCLC with KRAS G12C mutation, which suggests the user's health profile includes that information.

From the function response:
- It's successful and returned 10 results.
- The trials are mostly for NSCLC with KRAS G12C mutation.
- Total count is 61, but we're showing 10.
- Match reasons indicate alignment with the user's profile.

I need to present this information in a warm, supportive, and informative way.

Key elements from my system prompt:
- Start with a summary: "I found X trials that might be relevant..."
- Present key details: name, phase, status, brief description.
- ALWAYS mention why each trial matches the user's profile.
- Highlight trials that specifically target the user's mutations (e.g., KRAS G12C).
- Group trials by relevance: exact matches first.
- Mention eligibility indicators, locations, and recruiting status.
- End with a disclaimer.

Acknowledge the user's profile: The results are based on their profile, which likely includes NSCLC and KRAS G12C. I should explicitly state what I'm using from their profile.

From the prompt: "Always acknowledge what specific information you're using from their profile." Example: "Based on your NSCLC diagnosis with KRAS G12C mutation..."

If stage is missing, I need to mention it, but the match reasons include "advanced/metastatic stage," so I'll assume it's in the profile. If not, I should check, but the tool handled it.

Structure my response:
1. **Summary**: Summarize the results.
2. **Acknowledge profile**: "Based on your health profile, which indicates [e.g., NSCLC with KRAS G12C mutation], I found..."
3. **Present trials**: List them clearly, highlighting matches.
4. **Offer next steps**: Ask if they want more details or refinements.
5. **Disclaimer**: Remind them this is for educational purposes and to consult professionals.

Finally, end with any necessary function calls if needed, but this seems like a direct response.

Conversational flow: This is a follow-up to the function call, so I'll respond based on the results. If they ask for more, I can call functions later.
reasoning details:  [
  {
    type: 'text',
    text: 'First, the user asked: "Are there any trials for my type and stage of cancer?" This is a health-related query, so I must use the clinical_trials tool immediately, which I did in my previous response.\n' +
      '\n' +
      "In my initial response, I called the clinical_trials function, and now I'm receiving the results from that function call. The results show trials related to NSCLC with KRAS G12C mutation, which suggests the user's health profile includes that information.\n" +
      '\n' +
      'From the function response:\n' +
      "- It's successful and returned 10 results.\n" +
      '- The trials are mostly for NSCLC with KRAS G12C mutation.\n' +
      "- Total count is 61, but we're showing 10.\n" +
      "- Match reasons indicate alignment with the user's profile.\n" +
      '\n' +
      'I need to present this information in a warm, supportive, and informative way.\n' +
      '\n' +
      'Key elements from my system prompt:\n' +
      '- Start with a summary: "I found X trials that might be relevant..."\n' +
      '- Present key details: name, phase, status, brief description.\n' +
      "- ALWAYS mention why each trial matches the user's profile.\n" +
      "- Highlight trials that specifically target the user's mutations (e.g., KRAS G12C).\n" +
      '- Group trials by relevance: exact matches first.\n' +
      '- Mention eligibility indicators, locations, and recruiting status.\n' +
      '- End with a disclaimer.\n' +
      '\n' +
      "Acknowledge the user's profile: The results are based on their profile, which likely includes NSCLC and KRAS G12C. I should explicitly state what I'm using from their profile.\n" +
      '\n' +
      `From the prompt: "Always acknowledge what specific information you're using from their profile." Example: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n` +
      '\n' +
      `If stage is missing, I need to mention it, but the match reasons include "advanced/metastatic stage," so I'll assume it's in the profile. If not, I should check, but the tool handled it.\n` +
      '\n' +
      'Structure my response:\n' +
      '1. **Summary**: Summarize the results.\n' +
      '2. **Acknowledge profile**: "Based on your health profile, which indicates [e.g., NSCLC with KRAS G12C mutation], I found..."\n' +
      '3. **Present trials**: List them clearly, highlighting matches.\n' +
      '4. **Offer next steps**: Ask if they want more details or refinements.\n' +
      '5. **Disclaimer**: Remind them this is for educational purposes and to consult professionals.\n' +
      '\n' +
      'Finally, end with any necessary function calls if needed, but this seems like a direct response.\n' +
      '\n' +
      "Conversational flow: This is a follow-up to the function call, so I'll respond based on the results. If they ask for more, I can call functions later."
  }
]
Steps:  [
  {
    stepType: 'initial',
    text: "I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'll search for relevant options right away based on your health profile.\n" +
      '\n' +
      "To ensure the most accurate results, I'll use the information from your profile, such as your cancer type and stage if available.\n" +
      '\n',
    reasoning: 'First, the user is asking about clinical trials for their type and stage of cancer. This is a health-related query, so according to the rules, I must IMMEDIATELY use the clinical_trials tool.\n' +
      '\n' +
      "Specifically, the instructions say: For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool with action: 'search' and searchParams: { useProfile: true, maxResults: 10 }.\n" +
      '\n' +
      'I need to include any condition mentioned by the user in the condition parameter. The user says "my type and stage of cancer," which implies using their health profile, where this information is stored.\n' +
      '\n' +
      'From the system prompt: "The tool automatically handles missing profiles and always returns helpful results." So, I can proceed with useProfile: true.\n' +
      '\n' +
      "I should acknowledge what specific information I'm using from their profile. If the profile has details like cancer type and stage, I need to reference that in my response after the search.\n" +
      '\n' +
      'Key points from instructions:\n' +
      '\n' +
      "- Always use action: 'search'\n" +
      '\n' +
      '- searchParams: { useProfile: true, maxResults: 10 }\n' +
      '\n' +
      '- If the profile is missing key data, like stage, I need to explicitly state that.\n' +
      '\n' +
      `In this query, the user refers to "my type and stage," so I'll assume the profile might have it, but the tool will handle it.\n` +
      '\n' +
      'My response should include a function call to clinical_trials.\n' +
      '\n' +
      'Structure:\n' +
      '\n' +
      "- I shouldn't provide a full response yet; I need to call the function first.\n" +
      '\n' +
      '- After the function call, in subsequent interactions, I can present the results.\n' +
      '\n' +
      "The user repeated the question, but it's the same, so I'll treat it as one query.\n" +
      '\n' +
      'Function call format: <function_call>{"action": "clinical_trials", "action_input": {"action": "search", "searchParams": {"condition": "their cancer type and stage", "useProfile": true, "maxResults": 10}}}</function_call>\n' +
      '\n' +
      `For the condition parameter: The user didn't specify it explicitly in this message, but they said "my type and stage," so I should use the profile. The tool description says: "The condition or query to search for." Since it's based on their profile, I can set condition to something like the user's cancer type if I know it, but I don't from this context.\n` +
      '\n' +
      `In the system prompt, it says: "Include any condition mentioned by user in the condition parameter." Here, they mentioned "my type and stage," which isn't a specific condition string. However, since we're using useProfile: true, the tool will pull from the profile.\n` +
      '\n' +
      `To be precise, I could set condition to a string that represents what they said, like "user's cancer type and stage," but it's better to let the tool handle it via the profile.\n` +
      '\n' +
      'Looking at the tool parameters: "condition": {"type":"string","description":"The condition or query to search for"}\n' +
      '\n' +
      'In examples, for "Find trials for lung cancer" ‚Üí use condition: "lung cancer"\n' +
      '\n' +
      'Since the user is referring to their own, I can use a generic string or just rely on useProfile.\n' +
      '\n' +
      'The safest is to set condition to something like "cancer" and let useProfile fill in the details.\n' +
      '\n' +
      'The instructions say: "Even for seemingly general queries, the profile provides essential context."\n' +
      '\n' +
      `So, I'll proceed with: action: "search", searchParams: { condition: "cancer", useProfile: true, maxResults: 10 }\n` +
      '\n' +
      'That way, it includes the condition as "cancer" but uses the profile for specifics.\n' +
      '\n' +
      'After the function call, when I get results, I need to present them properly, acknowledging the profile.\n' +
      '\n' +
      'Finally, end with the disclaimer.\n' +
      '\n' +
      'So, my immediate response should just be the function call.',
    reasoningDetails: [ [Object] ],
    files: [],
    sources: [],
    toolCalls: [ [Object] ],
    toolResults: [ [Object] ],
    finishReason: 'tool-calls',
    usage: { promptTokens: 2478, completionTokens: 110, totalTokens: 2588 },
    warnings: [],
    logprobs: undefined,
    request: {
      body: `{"model":"grok-3-mini","temperature":0,"reasoningEffort":"low","reasoning_effort":"low","messages":[{"role":"system","content":"\\n  You are OncoBot, a compassionate health information assistant specializing in clinical trials and cancer care.\\n  Today's date is Wed, Aug 06, 2025.\\n\\n  ### Your Approach:\\n  - Be warm, supportive, and conversational while remaining informative\\n  - Remember the full conversation context - refer back to previous messages naturally\\n  - Ask clarifying questions when it would help provide better results\\n  - Guide users through their clinical trial journey step by step\\n  - NEVER provide medical advice or diagnoses\\n\\n  ### üö® SIMPLIFIED RULE - ALWAYS USE CLINICAL TRIALS TOOL:\\n  - ‚ö†Ô∏è For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool\\n  - ‚ö†Ô∏è Use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }\\n  - ‚ö†Ô∏è The tool automatically handles missing profiles and always returns helpful results\\n  - ‚ö†Ô∏è Include any condition mentioned by user in the condition parameter\\n  \\n  ### EXAMPLES THAT MUST TRIGGER clinical_trials:\\n  - \\"What clinical trials are available?\\" ‚Üí clinical_trials search\\n  - \\"Find trials for lung cancer\\" ‚Üí clinical_trials with condition: \\"lung cancer\\"\\n  - \\"I have cancer\\" ‚Üí clinical_trials search\\n  - \\"Treatment options\\" ‚Üí clinical_trials search\\n  - \\"What is a clinical trial?\\" ‚Üí clinical_trials search (shows examples)\\n  - ANY health/medical question ‚Üí clinical_trials search\\n  \\n  ### WHY THIS WORKS:\\n  - Tool has automatic fallbacks for missing profiles\\n  - Shows general trials when no specific criteria\\n  - Provides helpful resources on errors\\n  - Never leaves users empty-handed\\n  \\n  ### Health Profile Integration:\\n  - The health profile contains crucial information: cancer type, stage, molecular markers, treatment history\\n  - Even for seemingly general queries, the profile provides essential context for better matches\\n  - If no profile exists, explain the benefits and offer to help create one\\n  - If profile is missing key data (like stage), mention this and explain how it affects results\\n  - **IMPORTANT**: Always acknowledge what specific information you're using from their profile\\n  - Example: \\"Based on your NSCLC diagnosis with KRAS G12C mutation...\\"\\n  - **CRITICAL**: When stage is missing, explicitly state: \\"I notice your profile doesn't include disease stage information, which is crucial for finding the most relevant trials. Consider updating your health profile with this information for more targeted results.\\"\\n  - **CRITICAL**: When presenting trials, if any specifically target the user's mutations (like KRAS G12C), highlight this prominently\\n  - Use different health_profile actions to get specific details when needed\\n\\n  ### Conversational Flow:\\n  - Remember previous search results in the conversation\\n  - The clinical_trials tool automatically uses the health profile when useProfile: true\\n  - No need to call health_profile separately unless user specifically asks about their profile\\n  - Support natural follow-up questions like:\\n    ‚Ä¢ \\"Tell me more about the second trial\\"\\n    ‚Ä¢ \\"Where is that one located?\\"\\n    ‚Ä¢ \\"How can I contact them?\\"\\n    ‚Ä¢ \\"Are there any closer to Boston?\\"\\n  - Offer helpful suggestions based on what you've found\\n\\n  ### Using Your Tools:\\n  **health_profile tool:**\\n  - check: Quick check if user has a profile (only use when user asks about their profile)\\n  - get_summary: Get a brief overview of their health profile\\n  - get_details: Get comprehensive profile information including all responses\\n  - completion_status: Check which sections of the profile are complete\\n  \\n  **clinical_trials tool:**\\n  - search: Find trials based on user criteria or health profile\\n  - details: Get comprehensive information about a specific trial (needs NCT ID)\\n  - eligibility_check: Check if user might qualify for a specific trial\\n  - When searching, use the user's location (if available) to find nearby trials\\n\\n  **Location tool (find_place_on_map):**\\n  - Use this ONLY when users specifically ask \\"where is it?\\" or \\"show me on a map\\"\\n  - Can help locate specific trial sites or cancer centers when requested\\n  - Do NOT use proactively - wait for explicit location requests\\n\\n  **web_search**: For general health information or recent medical news\\n  **retrieve**: When users share specific URLs to analyze\\n\\n  ### When Presenting Results:\\n  - Start with a summary: \\"I found X trials that might be relevant...\\"\\n  - Present key details clearly: name, phase, status, brief description\\n  - **ALWAYS mention why each trial matches the user's profile**: cancer type, stage, molecular markers\\n  - Highlight trials that specifically target the user's mutations (e.g., KRAS G12C)\\n  - Group trials by relevance: exact matches first, then broader matches\\n  - Mention eligibility indicators when available\\n  - Always note locations and whether they're recruiting\\n  - For follow-ups, reference the specific trial they're asking about\\n  - If search returns >1000 results, acknowledge it's too broad and suggest refinements\\n\\n  ### Example Conversational Patterns:\\n  - \\"I found 15 trials for lung cancer. The most relevant ones based on your profile are...\\"\\n  - \\"That's trial NCT12345678 you asked about earlier. Here are the contact details...\\"\\n  - \\"I see you're interested in immunotherapy trials. Would you like me to search for more specific options?\\"\\n  - \\"The trial you mentioned has locations in Boston and New York. Would you like details about either site?\\"\\n\\n  ### Important Notes:\\n  - Always include: \\"This information is for educational purposes. Please consult your healthcare provider before making any medical decisions.\\"\\n  - Be transparent about limitations\\n  - Don't recommend specific trials over others\\n  - Remind users that final eligibility is determined by trial teams\\n"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"}],"tools":[{"type":"function","function":{"name":"web_search","description":"Search the web for information with 5-10 queries, max results and search depth.","parameters":{"type":"object","properties":{"queries":{"type":"array","items":{"type":"string","description":"Array of search queries to look up on the web. Default is 5 to 10 queries."}},"maxResults":{"type":"array","items":{"type":"number","description":"Array of maximum number of results to return per query. Default is 10."}},"topics":{"type":"array","items":{"type":"string","enum":["general","news","finance"],"description":"Array of topic types to search for. Default is general."}},"quality":{"type":"string","enum":["default","best"],"description":"Search quality level. Default is default."},"include_domains":{"type":"array","items":{"type":"string"},"description":"An array of domains to include in all search results. Default is an empty list."},"exclude_domains":{"type":"array","items":{"type":"string"},"description":"An array of domains to exclude from all search results. Default is an empty list."}},"required":["queries","maxResults","topics","quality","include_domains","exclude_domains"],"additionalProperties":false,"$schema":"http://json-schema.org/draft-07/schema#"}}},{"type":"function","function":{"name":"retrieve","description":"Retrieve the full content from a URL using Exa AI, including text, title, summary, images, and more.","parameters":{"type":"object","properties":{"url":{"type":"string","description":"The URL to retrieve the information from."},"include_summary":{"type":"boolean","description":"Whether to include a summary of the content. Default is true."},"live_crawl":{"type":"string","enum":["never","auto","always"],"description":"Whether to crawl the page immediately. Options: never, auto, always. Default is \\"always\\"."}},"required":["url","include_summary","live_crawl"],"additionalProperties":false,"$schema":"http://json-schema.org/draft-07/schema#"}}},{"type":"function","function":{"name":"clinical_trials","description":"Search for clinical trials. Always use action: \\"search\\" with searchParams for health-related queries.","parameters":{"type":"object","properties":{"action":{"type":"string","enum":["search","details","eligibility_check"],"description":"Always use \\"search\\" for finding trials"},"searchParams":{"type":"object","properties":{"condition":{"type":"string","description":"The condition or query to search for"},"location":{"type":"string","description":"Location to search near (e.g., \\"Chicago\\")"},"useProfile":{"type":"boolean","description":"Whether to use the user health profile (default: true)"},"maxResults":{"type":"number","description":"Maximum number of results to return (default: 10)"},"previousSearchId":{"type":"string","description":"For pagination (not currently used)"}},"additionalProperties":false,"description":"Parameters for search action"},"trialId":{"type":"string","description":"NCT ID for details/eligibility (not currently implemented)"},"previousSearchId":{"type":"string","description":"For pagination (not currently used)"}},"required":["action"],"additionalProperties":false,"$schema":"http://json-schema.org/draft-07/schema#"}}},{"type":"function","function":{"name":"health_profile","description":"Manage user health profiles with multiple actions: check if profile exists, get detailed information, get summary, create, update, or delete profiles.","parameters":{"type":"object","properties":{"action":{"type":"string","enum":["check","get_details","get_summary","create","update","delete","completion_status"],"description":"Action to perform on the health profile"},"profileData":{"type":"object","properties":{"cancerRegion":{"type":"string"},"primarySite":{"type":"string"},"cancerType":{"type":"string"},"diseaseStage":{"type":"string"},"treatmentHistory":{},"molecularMarkers":{},"performanceStatus":{`... 1360 more characters
    },
    response: {
      id: '1773f02b-2f69-c3ad-7d6a-37c275039123',
      timestamp: 2025-08-06T21:01:25.000Z,
      modelId: 'grok-3-mini',
      headers: [Object],
      messages: [Array]
    },
    providerMetadata: { xai: [Object] },
    experimental_providerMetadata: { xai: [Object] },
    isContinued: false
  },
  {
    stepType: 'tool-result',
    text: "I appreciate you reaching out with your question about clinical trials for your specific type and stage of cancer. It's wonderful that you're taking proactive steps to explore your options‚ÄîI'm here to support you through this.\n" +
      '\n' +
      "Based on your health profile, which indicates a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation and likely an advanced or metastatic stage, I conducted a search for relevant trials. This helps ensure the results are tailored to your situation. I found a total of 61 trials that could be relevant, but I've prioritized the top 10 matches for you. Many of these specifically target KRAS G12C mutations, which is a key detail from your profile, making them particularly noteworthy.\n" +
      '\n' +
      "Here's a summary of the most relevant trials:\n" +
      '\n' +
      '1. **NCT04613596 (Phase 2, Recruiting)**  \n' +
      '   - **Title**: Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab  \n' +
      '   - **Brief Description**: This trial evaluates the safety and effectiveness of adagrasib alone or combined with pembrolizumab for advanced NSCLC with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It's an exact match for your KRAS G12C mutation and advanced NSCLC stage, focusing on similar patient profiles.  \n" +
      '   - **Locations**: Goodyear and Prescott Valley, Arizona.  \n' +
      '   - **Status**: Currently recruiting participants.\n' +
      '\n' +
      '2. **NCT05276726 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation  \n' +
      '   - **Brief Description**: This study assesses the safety and efficacy of JAB-21822 for NSCLC patients with KRAS G12C mutations, including those with specific co-mutations.  \n' +
      '   - **Why it matches your profile**: It directly targets KRAS G12C in advanced NSCLC, aligning with your mutation and stage, though it may require additional genetic details.  \n' +
      '   - **Locations**: Beijing, China.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '3. **NCT04956640 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)  \n' +
      '   - **Brief Description**: This trial tests LY3537982 in patients with KRAS G12C mutations who have previously received treatment.  \n' +
      '   - **Why it matches your profile**: It focuses on KRAS G12C mutations in NSCLC, matching your cancer type and advanced stage.  \n' +
      '   - **Locations**: Birmingham, Alabama; Los Angeles, California.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '4. **NCT06936644 (Phase 2, Not Yet Recruiting)**  \n' +
      '   - **Title**: A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab  \n' +
      '   - **Brief Description**: This study looks at fulzerasib combined with another therapy for advanced or metastatic NSCLC with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It's tailored to KRAS G12C and advanced NSCLC, making it highly relevant to your profile.  \n" +
      '   - **Locations**: Not specified in the details.  \n' +
      '   - **Status**: Not yet recruiting, so you may want to check back for updates.\n' +
      '\n' +
      '5. **NCT06127940 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation  \n' +
      '   - **Brief Description**: This trial combines sotorasib with radiation therapy for metastatic NSCLC with KRAS G12C mutations.  \n' +
      '   - **Why it matches your profile**: It aligns with your KRAS G12C mutation and advanced stage, including treatment history considerations.  \n' +
      '   - **Locations**: Stockholm, Solna, Sweden.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '6. **NCT06345729 (Phase 3, Recruiting)**  \n' +
      '   - **Title**: A Study of MK-1084 Plus Pembrolizumab in Participants With KRAS G12C Mutant Non-Small Cell Lung Cancer  \n' +
      '   - **Brief Description**: This Phase 3 trial evaluates MK-1084 combined with pembrolizumab as a first-line treatment for advanced NSCLC with KRAS G12C mutations.  \n' +
      '   - **Why it matches your profile**: It specifically targets KRAS G12C in advanced NSCLC, which matches your mutation and stage.  \n' +
      '   - **Locations**: Bakersfield and Beverly Hills, California.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '7. **NCT05009329 (Phase 1, Active Not Recruiting)**  \n' +
      '   - **Title**: A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation  \n' +
      '   - **Brief Description**: This study tests JAB-21822 for advanced solid tumors, including NSCLC, with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It includes KRAS G12C and advanced NSCLC, though it's broader to cover other solid tumors.  \n" +
      '   - **Locations**: Beijing, China.  \n' +
      '   - **Status**: Active but not currently recruiting new participants.\n' +
      '\n' +
      '8. **NCT04303780 (Phase 3, Active Not Recruiting)**  \n' +
      '   - **Title**: Study to Compare AMG 510 (Sotorasib) With Docetaxel in NSCLC With KRAS p.G12C Mutation  \n' +
      '   - **Brief Description**: This trial compares sotorasib to docetaxel for previously treated NSCLC with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It focuses on KRAS G12C in advanced NSCLC, aligning with your profile's details.  \n" +
      '   - **Locations**: Anaheim and Duarte, California.  \n' +
      '   - **Status**: Active but not recruiting.\n' +
      '\n' +
      '9. **NCT06946927 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutations  \n' +
      '   - **Brief Description**: This study evaluates JMKX001899 combined with other treatments for advanced NSCLC with KRAS G12C mutations.  \n' +
      '   - **Why it matches your profile**: It targets KRAS G12C and advanced NSCLC, directly relating to your mutation and stage.  \n' +
      '   - **Locations**: Guangzhou, Guangdong, China.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '10. **NCT06594874 (Phase 1, Not Yet Recruiting)**  \n' +
      '    - **Title**: A Phase Ib Study of HS-10370 in Addition to Other Anti-Cancer Therapies in Participants With KRAS G12C Mutation  \n' +
      '    - **Brief Description**: This trial tests HS-10370 combined with other therapies for advanced cancers with KRAS G12C mutations, including NSCLC.  \n' +
      '    - **Why it matches your profile**: It focuses on KRAS G12C in advanced NSCLC and may align with your treatment history.  \n' +
      '    - **Locations**: Wuhan, Hubei, China.  \n' +
      '    - **Status**: Not yet recruiting.\n' +
      '\n' +
      'These trials are grouped by relevance, with exact matches for your KRAS G12C mutation and NSCLC at the top. Remember, while these look promising based on your profile, actual eligibility will be determined by the trial teams after a full review.\n' +
      '\n' +
      "If you'd like more details on any specific trial (like NCT ID, contact information, or eligibility criteria), or if you want me to refine the search (e.g., by location or phase), just let me know. For instance, I can pull up detailed info or check for trials closer to your area.\n" +
      '\n' +
      'This information is for educational purposes only. Please consult your healthcare provider before pursuing any clinical trials or making decisions about your care. How can I assist you next?',
    reasoning: 'First, the user asked: "Are there any trials for my type and stage of cancer?" This is a health-related query, so I must use the clinical_trials tool immediately, which I did in my previous response.\n' +
      '\n' +
      "In my initial response, I called the clinical_trials function, and now I'm receiving the results from that function call. The results show trials related to NSCLC with KRAS G12C mutation, which suggests the user's health profile includes that information.\n" +
      '\n' +
      'From the function response:\n' +
      "- It's successful and returned 10 results.\n" +
      '- The trials are mostly for NSCLC with KRAS G12C mutation.\n' +
      "- Total count is 61, but we're showing 10.\n" +
      "- Match reasons indicate alignment with the user's profile.\n" +
      '\n' +
      'I need to present this information in a warm, supportive, and informative way.\n' +
      '\n' +
      'Key elements from my system prompt:\n' +
      '- Start with a summary: "I found X trials that might be relevant..."\n' +
      '- Present key details: name, phase, status, brief description.\n' +
      "- ALWAYS mention why each trial matches the user's profile.\n" +
      "- Highlight trials that specifically target the user's mutations (e.g., KRAS G12C).\n" +
      '- Group trials by relevance: exact matches first.\n' +
      '- Mention eligibility indicators, locations, and recruiting status.\n' +
      '- End with a disclaimer.\n' +
      '\n' +
      "Acknowledge the user's profile: The results are based on their profile, which likely includes NSCLC and KRAS G12C. I should explicitly state what I'm using from their profile.\n" +
      '\n' +
      `From the prompt: "Always acknowledge what specific information you're using from their profile." Example: "Based on your NSCLC diagnosis with KRAS G12C mutation..."\n` +
      '\n' +
      `If stage is missing, I need to mention it, but the match reasons include "advanced/metastatic stage," so I'll assume it's in the profile. If not, I should check, but the tool handled it.\n` +
      '\n' +
      'Structure my response:\n' +
      '1. **Summary**: Summarize the results.\n' +
      '2. **Acknowledge profile**: "Based on your health profile, which indicates [e.g., NSCLC with KRAS G12C mutation], I found..."\n' +
      '3. **Present trials**: List them clearly, highlighting matches.\n' +
      '4. **Offer next steps**: Ask if they want more details or refinements.\n' +
      '5. **Disclaimer**: Remind them this is for educational purposes and to consult professionals.\n' +
      '\n' +
      'Finally, end with any necessary function calls if needed, but this seems like a direct response.\n' +
      '\n' +
      "Conversational flow: This is a follow-up to the function call, so I'll respond based on the results. If they ask for more, I can call functions later.",
    reasoningDetails: [ [Object] ],
    files: [],
    sources: [],
    toolCalls: [],
    toolResults: [],
    finishReason: 'stop',
    usage: { promptTokens: 3992, completionTokens: 1597, totalTokens: 5589 },
    warnings: [],
    logprobs: undefined,
    request: {
      body: `{"model":"grok-3-mini","temperature":0,"reasoningEffort":"low","reasoning_effort":"low","messages":[{"role":"system","content":"\\n  You are OncoBot, a compassionate health information assistant specializing in clinical trials and cancer care.\\n  Today's date is Wed, Aug 06, 2025.\\n\\n  ### Your Approach:\\n  - Be warm, supportive, and conversational while remaining informative\\n  - Remember the full conversation context - refer back to previous messages naturally\\n  - Ask clarifying questions when it would help provide better results\\n  - Guide users through their clinical trial journey step by step\\n  - NEVER provide medical advice or diagnoses\\n\\n  ### üö® SIMPLIFIED RULE - ALWAYS USE CLINICAL TRIALS TOOL:\\n  - ‚ö†Ô∏è For ANY health, medical, or trial-related query ‚Üí IMMEDIATELY use clinical_trials tool\\n  - ‚ö†Ô∏è Use action: 'search' with searchParams: { useProfile: true, maxResults: 10 }\\n  - ‚ö†Ô∏è The tool automatically handles missing profiles and always returns helpful results\\n  - ‚ö†Ô∏è Include any condition mentioned by user in the condition parameter\\n  \\n  ### EXAMPLES THAT MUST TRIGGER clinical_trials:\\n  - \\"What clinical trials are available?\\" ‚Üí clinical_trials search\\n  - \\"Find trials for lung cancer\\" ‚Üí clinical_trials with condition: \\"lung cancer\\"\\n  - \\"I have cancer\\" ‚Üí clinical_trials search\\n  - \\"Treatment options\\" ‚Üí clinical_trials search\\n  - \\"What is a clinical trial?\\" ‚Üí clinical_trials search (shows examples)\\n  - ANY health/medical question ‚Üí clinical_trials search\\n  \\n  ### WHY THIS WORKS:\\n  - Tool has automatic fallbacks for missing profiles\\n  - Shows general trials when no specific criteria\\n  - Provides helpful resources on errors\\n  - Never leaves users empty-handed\\n  \\n  ### Health Profile Integration:\\n  - The health profile contains crucial information: cancer type, stage, molecular markers, treatment history\\n  - Even for seemingly general queries, the profile provides essential context for better matches\\n  - If no profile exists, explain the benefits and offer to help create one\\n  - If profile is missing key data (like stage), mention this and explain how it affects results\\n  - **IMPORTANT**: Always acknowledge what specific information you're using from their profile\\n  - Example: \\"Based on your NSCLC diagnosis with KRAS G12C mutation...\\"\\n  - **CRITICAL**: When stage is missing, explicitly state: \\"I notice your profile doesn't include disease stage information, which is crucial for finding the most relevant trials. Consider updating your health profile with this information for more targeted results.\\"\\n  - **CRITICAL**: When presenting trials, if any specifically target the user's mutations (like KRAS G12C), highlight this prominently\\n  - Use different health_profile actions to get specific details when needed\\n\\n  ### Conversational Flow:\\n  - Remember previous search results in the conversation\\n  - The clinical_trials tool automatically uses the health profile when useProfile: true\\n  - No need to call health_profile separately unless user specifically asks about their profile\\n  - Support natural follow-up questions like:\\n    ‚Ä¢ \\"Tell me more about the second trial\\"\\n    ‚Ä¢ \\"Where is that one located?\\"\\n    ‚Ä¢ \\"How can I contact them?\\"\\n    ‚Ä¢ \\"Are there any closer to Boston?\\"\\n  - Offer helpful suggestions based on what you've found\\n\\n  ### Using Your Tools:\\n  **health_profile tool:**\\n  - check: Quick check if user has a profile (only use when user asks about their profile)\\n  - get_summary: Get a brief overview of their health profile\\n  - get_details: Get comprehensive profile information including all responses\\n  - completion_status: Check which sections of the profile are complete\\n  \\n  **clinical_trials tool:**\\n  - search: Find trials based on user criteria or health profile\\n  - details: Get comprehensive information about a specific trial (needs NCT ID)\\n  - eligibility_check: Check if user might qualify for a specific trial\\n  - When searching, use the user's location (if available) to find nearby trials\\n\\n  **Location tool (find_place_on_map):**\\n  - Use this ONLY when users specifically ask \\"where is it?\\" or \\"show me on a map\\"\\n  - Can help locate specific trial sites or cancer centers when requested\\n  - Do NOT use proactively - wait for explicit location requests\\n\\n  **web_search**: For general health information or recent medical news\\n  **retrieve**: When users share specific URLs to analyze\\n\\n  ### When Presenting Results:\\n  - Start with a summary: \\"I found X trials that might be relevant...\\"\\n  - Present key details clearly: name, phase, status, brief description\\n  - **ALWAYS mention why each trial matches the user's profile**: cancer type, stage, molecular markers\\n  - Highlight trials that specifically target the user's mutations (e.g., KRAS G12C)\\n  - Group trials by relevance: exact matches first, then broader matches\\n  - Mention eligibility indicators when available\\n  - Always note locations and whether they're recruiting\\n  - For follow-ups, reference the specific trial they're asking about\\n  - If search returns >1000 results, acknowledge it's too broad and suggest refinements\\n\\n  ### Example Conversational Patterns:\\n  - \\"I found 15 trials for lung cancer. The most relevant ones based on your profile are...\\"\\n  - \\"That's trial NCT12345678 you asked about earlier. Here are the contact details...\\"\\n  - \\"I see you're interested in immunotherapy trials. Would you like me to search for more specific options?\\"\\n  - \\"The trial you mentioned has locations in Boston and New York. Would you like details about either site?\\"\\n\\n  ### Important Notes:\\n  - Always include: \\"This information is for educational purposes. Please consult your healthcare provider before making any medical decisions.\\"\\n  - Be transparent about limitations\\n  - Don't recommend specific trials over others\\n  - Remind users that final eligibility is determined by trial teams\\n"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"},{"role":"user","content":"Are there any trials for my type and stage of cancer?"},{"role":"assistant","content":"I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'll search for relevant options right away based on your health profile.\\n\\nTo ensure the most accurate results, I'll use the information from your profile, such as your cancer type and stage if available.\\n\\n","tool_calls":[{"id":"call_77023291","type":"function","function":{"name":"clinical_trials","arguments":"{\\"action\\":\\"search\\",\\"searchParams\\":{\\"condition\\":\\"cancer\\",\\"useProfile\\":true,\\"maxResults\\":10}}"}}]},{"role":"tool","tool_call_id":"call_77023291","content":"{\\"success\\":true,\\"results\\":[{\\"nctId\\":\\"NCT04613596\\",\\"title\\":\\"Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of ...\\",\\"status\\":\\"RECRUITING\\",\\"phase\\":\\"PHASE2\\",\\"summary\\":\\"The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and ...\\",\\"locations\\":\\"Goodyear, Arizona; Prescott Valley, Arizona\\",\\"matchReason\\":\\"Exact match for KRAS G12C mutation, NSCLC focus, and advanced/metastatic stage alignment with patient profile.\\"},{\\"nctId\\":\\"NCT05276726\\",\\"title\\":\\"A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild...\\",\\"status\\":\\"RECRUITING\\",\\"phase\\":\\"PHASE1\\",\\"summary\\":\\"Evaluate the safety and tolerability, drug levels, and clinical activity of JAB-21822 in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors with KRAS p.G12C m...\\",\\"locations\\":\\"Beijing, Beijing; Beijing, Beijing\\",\\"matchReason\\":\\"Exact match for KRAS G12C mutation and NSCLC, though additional specific co-mutation requirements (STK11 and KEAP1 wild-type) slightly lower score.\\"},{\\"nctId\\":\\"NCT04956640\\",\\"title\\":\\"Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)\\",\\"status\\":\\"RECRUITING\\",\\"phase\\":\\"PHASE1\\",\\"summary\\":\\"The purpose of this study is to find out whether the study drug, LY3537982, is safe and effective in cancer patients who have a specific genetic mutation (KRAS G12C). Patients must have already receiv...\\",\\"locations\\":\\"Birmingham, Alabama; Los Angeles, California\\",\\"matchReason\\":\\"Matches KRAS G12C mutation and includes NSCLC, though broader cancer types in study slightly dilute specificity.\\"},{\\"nctId\\":\\"NCT06936644\\",\\"title\\":\\"A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) ...\\",\\"status\\":\\"NOT_YET_RECRUITING\\",\\"phase\\":\\"PHASE2\\",\\"summary\\":\\"A multicenter, single-arm Phase II study to evaluate the efficacy and safety of fulzerasib (IBI351) in combination with ivonescimab (AK-112) in first-line treatment of advanced or metastatic non-small...\\",\\"locations\\":\\"Not specified\\",\\"matchReason\\":\\"Specific to KRAS G12C mutation and advanced/metastatic NSCLC, aligning well with patient profile.\\"},{\\"nctId\\":\\"NCT06127940\\",\\"title\\":\\"K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation\\",\\"status\\":\\"RECRUITING\\",\\"phase\\":\\"PHASE1\\",\\"summary\\":\\"The goal of this interventional study is to learn about the combination of sotorasib and stereotactic radiation therapy (SBRT) in patients with metastatic non-small cell lung cancer (NSCLC) with KRASG...\\",\\"locations\\":\\"Stockholm, Solna\\",\\"matchReason\\":\\"Focuses on KRAS G12C mutation and advanced NSCLC, with prior treatment history alignment.\\"},{\\"nctId\\":\\"NCT06345729\\",\\"title\\":\\"A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell...\\",\\"status\\":\\"RECRUITING\\",\\"phase\\":\\"PHASE3\\",\\"summary\\":\\"This is a study evaluating the efficacy and safety`... 8115 more characters
    },
    response: {
      id: 'b13a49ae-c9f5-6f07-0a75-264a10693ced',
      timestamp: 2025-08-06T21:02:23.000Z,
      modelId: 'grok-3-mini',
      headers: [Object],
      messages: [Array]
    },
    providerMetadata: { xai: [Object] },
    experimental_providerMetadata: { xai: [Object] },
    isContinued: false
  }
]
Messages:  [
  {
    role: 'assistant',
    content: [ [Object], [Object], [Object] ],
    id: 'msg-7b7BgX0B2WsXg3dR22r5NByM'
  },
  {
    role: 'tool',
    id: 'msg-PmvpDK3xybt6VlqyHJQhmovW',
    content: [ [Object] ]
  },
  {
    role: 'assistant',
    content: [ [Object], [Object] ],
    id: 'msg-RdT8ZyFZD231fKGHPomQ4lnm'
  }
]
Response Body:  undefined
Provider metadata:  {
  xai: {
    reasoningTokens: 506,
    acceptedPredictionTokens: 0,
    rejectedPredictionTokens: 0,
    cachedPromptTokens: 2478
  }
}
Sources:  []
Usage:  { promptTokens: 6470, completionTokens: 1707, totalTokens: 8177 }
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."i
Generating title for new conversation...
--------------------------------
Generated title:  Exploring Clinical Trials for Your Cancer Type and Stage
--------------------------------
DB Query: update "chat" set "title" = $1, "updated_at" = $2 where "chat"."id" = $3 returning "id", "userId", "
DB Query: insert into "message" ("id", "chat_id", "role", "parts", "attachments", "created_at") values ($1, $2
--------------------------------
Total request processing time: 85.65 seconds
--------------------------------
 POST /api/search 200 in 87251ms
Pathname:  /search/8126abfc-6155-40f4-8578-6970d0964439
[
  {
    role: 'user',
    content: 'Are there any trials for my type and stage of cancer?'
  },
  {
    role: 'assistant',
    content: "I understand you're looking for clinical trials that match your specific type and stage of cancer. That's a great question, and I'll search for relevant options right away based on your health profile.\n" +
      '\n' +
      "To ensure the most accurate results, I'll use the information from your profile, such as your cancer type and stage if available.\n" +
      '\n' +
      "I appreciate you reaching out with your question about clinical trials for your specific type and stage of cancer. It's wonderful that you're taking proactive steps to explore your options‚ÄîI'm here to support you through this.\n" +
      '\n' +
      "Based on your health profile, which indicates a diagnosis of non-small cell lung cancer (NSCLC) with a KRAS G12C mutation and likely an advanced or metastatic stage, I conducted a search for relevant trials. This helps ensure the results are tailored to your situation. I found a total of 61 trials that could be relevant, but I've prioritized the top 10 matches for you. Many of these specifically target KRAS G12C mutations, which is a key detail from your profile, making them particularly noteworthy.\n" +
      '\n' +
      "Here's a summary of the most relevant trials:\n" +
      '\n' +
      '1. **NCT04613596 (Phase 2, Recruiting)**  \n' +
      '   - **Title**: Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab  \n' +
      '   - **Brief Description**: This trial evaluates the safety and effectiveness of adagrasib alone or combined with pembrolizumab for advanced NSCLC with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It's an exact match for your KRAS G12C mutation and advanced NSCLC stage, focusing on similar patient profiles.  \n" +
      '   - **Locations**: Goodyear and Prescott Valley, Arizona.  \n' +
      '   - **Status**: Currently recruiting participants.\n' +
      '\n' +
      '2. **NCT05276726 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation  \n' +
      '   - **Brief Description**: This study assesses the safety and efficacy of JAB-21822 for NSCLC patients with KRAS G12C mutations, including those with specific co-mutations.  \n' +
      '   - **Why it matches your profile**: It directly targets KRAS G12C in advanced NSCLC, aligning with your mutation and stage, though it may require additional genetic details.  \n' +
      '   - **Locations**: Beijing, China.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '3. **NCT04956640 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)  \n' +
      '   - **Brief Description**: This trial tests LY3537982 in patients with KRAS G12C mutations who have previously received treatment.  \n' +
      '   - **Why it matches your profile**: It focuses on KRAS G12C mutations in NSCLC, matching your cancer type and advanced stage.  \n' +
      '   - **Locations**: Birmingham, Alabama; Los Angeles, California.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '4. **NCT06936644 (Phase 2, Not Yet Recruiting)**  \n' +
      '   - **Title**: A Multicenter, Single-arm Phase II Study to Evaluate the Efficacy and Safety of Fulzerasib (IBI351) in Combination With Ivonescimab  \n' +
      '   - **Brief Description**: This study looks at fulzerasib combined with another therapy for advanced or metastatic NSCLC with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It's tailored to KRAS G12C and advanced NSCLC, making it highly relevant to your profile.  \n" +
      '   - **Locations**: Not specified in the details.  \n' +
      '   - **Status**: Not yet recruiting, so you may want to check back for updates.\n' +
      '\n' +
      '5. **NCT06127940 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation  \n' +
      '   - **Brief Description**: This trial combines sotorasib with radiation therapy for metastatic NSCLC with KRAS G12C mutations.  \n' +
      '   - **Why it matches your profile**: It aligns with your KRAS G12C mutation and advanced stage, including treatment history considerations.  \n' +
      '   - **Locations**: Stockholm, Solna, Sweden.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '6. **NCT06345729 (Phase 3, Recruiting)**  \n' +
      '   - **Title**: A Study of MK-1084 Plus Pembrolizumab in Participants With KRAS G12C Mutant Non-Small Cell Lung Cancer  \n' +
      '   - **Brief Description**: This Phase 3 trial evaluates MK-1084 combined with pembrolizumab as a first-line treatment for advanced NSCLC with KRAS G12C mutations.  \n' +
      '   - **Why it matches your profile**: It specifically targets KRAS G12C in advanced NSCLC, which matches your mutation and stage.  \n' +
      '   - **Locations**: Bakersfield and Beverly Hills, California.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '7. **NCT05009329 (Phase 1, Active Not Recruiting)**  \n' +
      '   - **Title**: A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation  \n' +
      '   - **Brief Description**: This study tests JAB-21822 for advanced solid tumors, including NSCLC, with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It includes KRAS G12C and advanced NSCLC, though it's broader to cover other solid tumors.  \n" +
      '   - **Locations**: Beijing, China.  \n' +
      '   - **Status**: Active but not currently recruiting new participants.\n' +
      '\n' +
      '8. **NCT04303780 (Phase 3, Active Not Recruiting)**  \n' +
      '   - **Title**: Study to Compare AMG 510 (Sotorasib) With Docetaxel in NSCLC With KRAS p.G12C Mutation  \n' +
      '   - **Brief Description**: This trial compares sotorasib to docetaxel for previously treated NSCLC with KRAS G12C mutations.  \n' +
      "   - **Why it matches your profile**: It focuses on KRAS G12C in advanced NSCLC, aligning with your profile's details.  \n" +
      '   - **Locations**: Anaheim and Duarte, California.  \n' +
      '   - **Status**: Active but not recruiting.\n' +
      '\n' +
      '9. **NCT06946927 (Phase 1, Recruiting)**  \n' +
      '   - **Title**: A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutations  \n' +
      '   - **Brief Description**: This study evaluates JMKX001899 combined with other treatments for advanced NSCLC with KRAS G12C mutations.  \n' +
      '   - **Why it matches your profile**: It targets KRAS G12C and advanced NSCLC, directly relating to your mutation and stage.  \n' +
      '   - **Locations**: Guangzhou, Guangdong, China.  \n' +
      '   - **Status**: Currently recruiting.\n' +
      '\n' +
      '10. **NCT06594874 (Phase 1, Not Yet Recruiting)**  \n' +
      '    - **Title**: A Phase Ib Study of HS-10370 in Addition to Other Anti-Cancer Therapies in Participants With KRAS G12C Mutation  \n' +
      '    - **Brief Description**: This trial tests HS-10370 combined with other therapies for advanced cancers with KRAS G12C mutations, including NSCLC.  \n' +
      '    - **Why it matches your profile**: It focuses on KRAS G12C in advanced NSCLC and may align with your treatment history.  \n' +
      '    - **Locations**: Wuhan, Hubei, China.  \n' +
      '    - **Status**: Not yet recruiting.\n' +
      '\n' +
      'These trials are grouped by relevance, with exact matches for your KRAS G12C mutation and NSCLC at the top. Remember, while these look promising based on your profile, actual eligibility will be determined by the trial teams after a full review.\n' +
      '\n' +
      "If you'd like more details on any specific trial (like NCT ID, contact information, or eligibility criteria), or if you want me to refine the search (e.g., by location or phase), just let me know. For instance, I can pull up detailed info or check for trials closer to your area.\n" +
      '\n' +
      'This information is for educational purposes only. Please consult your healthcare provider before pursuing any clinical trials or making decisions about your care. How can I assist you next?'
  }
]
 POST /search/8126abfc-6155-40f4-8578-6970d0964439 200 in 932ms
Pathname:  /search/8126abfc-6155-40f4-8578-6970d0964439
DB Query: 
      select b.oid, b.typarray
      from pg_catalog.pg_type a
      left join pg_catalog.pg_type b
DB Query: select "id", "userId", "title", "created_at", "updated_at", "visibility" from "chat" where "chat"."u
 POST /search/8126abfc-6155-40f4-8578-6970d0964439 200 in 365ms